Elenco degli articoli con argomento «psoriasi»

Dermatologia

21 gen 2020

Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice

Fumaric acid ester (FAE) is the most commonly prescribed first-line systemic therapy for the treatment of psoriasis in Germany.

15 gen 2020

Persistence of inflammatory phenotype in residual psoriatic plaques in patients on effective biologic therapy

Residual Psoriatic Plaques After Treatment

15 gen 2020

A systematic review of treatment strategies for erythrodermic psoriasis

Erythrodermic psoriasis (EP) is a severe, rare form of psoriasis that can be life threatening. Treatment of EP is usually based on anecdotal evidence or past clinical experience, which is in part due to the rarity and often emergent nature of this psoriasis subtype.

07 gen 2020

Comparing psoriasis advertisement methods with patient willingness to initiate treatment

Many patients with psoriasis struggle with taking biologic agents. The way in which providers present medications could enhance treatment adherence.

07 gen 2020

Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument (APso‐QOL)

a disease‐specific measure of quality of life in adolescents with psoriasis

09 dic 2019

Psoriasi: conosciuta ma decisamente sottotrattata. E i pazienti vivono in preda all’ansia navigation-next-alternate

Sono i risultati scaturiti da due studi presentati a Madrid dove in questi giorni è in corso il 28° congresso dell’EADV.

09 dic 2019

Prurito: che cosa lo può provocare, come si controlla e quando è spia di problemi seri navigation-next-alternate

Se si escludono le punture di insetti, nella maggior parte dei casi la ragione di quell’impulso è da ricercare in una patologia dermatologica. Ma anche in alcune abitudini scorrette e malattie sistemiche

09 dic 2019

Predictors of hospital readmission in US adults with psoriasis

Readmission in Psoriasis

02 dic 2019

Psoriasi: fototerapia da preferire contro il dolore navigation-next-alternate

Psoriasi, fototerapia meglio di adalimumab nel migliorare dolore e qualità di vita secondo uno studio pubblicato sul Journal of American Academy of Dermatology

17 nov 2019

Tofacitinib in Pediatric Psoriasis: An Open-Label Trial to Study Its Safety and Efficacy in Children

Psoriasis is a chronic, multifactorial, inflammatory disorder, with an estimated prevalence of 0.71% in children.

29 ott 2019

Skin changes in the obese patient

Obesity is a worldwide major public health problem with an alarmingly increasing prevalence over the past 2 decades.

29 ott 2019

Risk of Major Cardiovascular Events in Patients with Psoriasis Receiving Biologic Therapies: a Prospective Cohort Study.

The cardiovascular safety profile of biologic therapies used for psoriasis is unclear.

15 ott 2019

Psoriasi: farmaci biologici sempre più efficaci e sicuri navigation-next-alternate

Gli anticorpi migliorano significativamente i sintomi della malattia. No al “fai da te”. Sul web troppi video privi di contenuto scientifico

08 ott 2019

La psoriasi è la malattia dei sani navigation-next-alternate

E' vero che ... La psoriasi è la malattia dei sani

25 set 2019

Dietary compounds as potential modulators of microRNA expression in psoriasis

This review aims to summarize knowledge about aberrant microRNAs expression in psoriasis

11 set 2019

Psoriasi a placche, Fda approva farmaco per l'uso negli adolescenti dai 12 anni di età navigation-next-alternate

La Food and Drug Administration (FDA) degli Stati Uniti ha approvato calcipotriene 0,005% formulato in schiuma, commercializzato da Mayne Pharma Group, per il trattamento della psoriasi a placche del cuoio capelluto e del corpo negli adolescenti di almeno 12 anni di età.

03 set 2019

Effects of psoriasis treatment on genital warts: a case report. navigation-next-alternate

The use of immunosuppressive drugs predisposes to infections, as they block the most important stage in antiviral defense, which is the cytotoxic T-lymphocyte HLA-dependent response.

03 set 2019

Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission.

There is increasing interest in discontinuing biological therapies in patients with chronic plaque psoriasis (PsO) who achieve a complete clinical remission, provided patients maintain clinical benefit.

24 lug 2019

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis navigation-next-alternate

2019 May 24;9:29-35. doi: 10.2147/PTT.S179283. eCollection 2019.

07 giu 2019

Non trattare la pelle con superficialità navigation-next-alternate

Campagna informativa